NCT07053163View on ClinicalTrials.gov

Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

September 30, 2024

Conditions
Mortality RateHemorrhagic Shock
Interventions
DRUG

Crystalloid and blood as resuscitation

Patients receive crystalloid and blood as resuscitation

DRUG

crystalloid, blood and low dose of norepinephrine

Group 2: receive crystalloid, blood and low dose of norepinephrine

Trial Locations (1)

Unknown

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07053163 - Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock | Biotech Hunter | Biotech Hunter